The Relevance of Women's Diseases, Jun Activation-domain Binding Protein 1 (JAB1) and p27(kip1)

Mijin Kim1, Tae-Hee Kim2, Hae-Hyeog Lee2

  • 1Department of Interdisciplinary Program in Biomedical Science, Soonchunhyang University, Asan, Korea.

Insights

Jun activation-domain binding protein 1 (Jab1) interacts with p27(kip1), a cell cycle regulator. This interaction, mediated by the ubiquitin/proteasome pathway, influences cell proliferation and apoptosis, offering insights into disease mechanisms.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Jun activation-domain binding protein 1 (Jab1) is a coactivator for transcription factors like activator protein 1 (AP-1) and a component of the COP9 signalosome.
  • p27(kip1) is a crucial cell cycle inhibitor, tumor suppressor, and regulator of apoptosis.

Purpose of the Study:

  • To elucidate the functional and structural relationship between Jab1 and p27(kip1).
  • To understand how Jab1 influences p27(kip1) localization and function within the cell.

Main Methods:

  • The study likely involved molecular biology techniques to investigate protein-protein interactions.
  • Analysis of protein localization and degradation pathways, including the ubiquitin/proteasome system.

Main Results:

  • Jab1 and p27(kip1) interact, with Jab1 promoting the nuclear-to-cytoplasmic translocation of p27(kip1).
  • Jab1's action on p27(kip1) is facilitated through the ubiquitin/proteasome pathway.
  • This interaction impacts cell proliferation and potentially apoptosis.

Conclusions:

  • The study identifies a novel interaction and regulatory mechanism between Jab1 and p27(kip1).
  • Understanding this relationship provides insights into cell cycle control and disease pathogenesis.
  • Further research may explore the implications for women's health and disease management.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K